Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development
Company Poised to Enter Booming Bispecific Antibody Market Amid Growing Pharma InterestProvidence, RI, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Ocean ...
Weakness in lung cancer's defenses found—an enzyme that boosts cancer cell metabolism
Lung cancer is a particularly challenging form of cancer. It often strikes unexpectedly and aggressively with little warning, ...
Metastatic cancers: Targeting a protein that fuels treatment-resistant tumors may be key to better outcomes
One of the biggest challenges in cancer treatment is addressing the ability of cancer cells to adapt and become resistant, ...
Science Daily6d
Computer model helps identify cancer-fighting immune cells key to immunotherapy
Researchers have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune checkpoint inhibitors.
Cancer Rates Are Falling in Appalachia, But Not Enough
However, rates of cancer incidence and death are going down, if slowly, in Appalachia. Rates of new cases in Appalachia have ...
earth5d
Computer model can identify tumor-fighting immune cells
Researchers have developed a groundbreaking AI model that identifies tumor-fighting immune cells, enhancing cancer ...
Brooklyn inmate gets reduced sentence after MDC botches cancer treatment
Terrence Wise’s medical mistreatment at the notorious federal lockup reduced his chance of surviving past five years to about ...
Cancer doctor shares which five types of the disease are most 'lethal'
A cancer expert has shared the five types of cancer which are considered the most "lethal", and claimed people diagnosed with ...
Boston hospital offers one-visit procedure to treat lung cancer
BOSTON - Patients with lung nodules often have to undergo several procedures including biopsy and multiple surgeries, but a ...
Ocean Biomedical advances in cancer immunotherapy
PROVIDENCE, RI - Ocean Biomedical (NASDAQ: OCEA) has announced research findings that show its immunotherapy candidates can work synergistically with tyrosine kinase inhibitors (TKIs), potentially ...